SCHEMBL7959943

SCHEMBL7959943

Cc1ccc(N)c(N)c1CN(C)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
KDM4E B2RXH2 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
CARM1 Q86X55 1/20 0.46
PRMT6 Q96LA8 1/20 0.46
PRMT8 Q9NR22 1/20 0.46
KMT2A Q03164 2/20 0.43
AOC3 Q16853 1/20 0.43
HSD17B10 Q99714 2/20 0.43
TSHR P16473 3/20 0.41
LMNA P02545 3/20 0.41
USP2 O75604 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
PYCR1 P32322 1/20 0.41
GAA P10253 3/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
CASP1 P29466 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23295626 0.81 IDH1 (0.44) ALDH1A1KDM4ETSHRCYP3A4
SCHEMBL2574713 0.75 CYP2D6 (0.46) SMN1; SMN2AOC3MAOAMAOB
SCHEMBL31357517 0.75 CYP2D6 (0.46) SMN1; SMN2AOC3MAOAMAOB
Dibemethine SCHEMBL10542007 0.74 ALDH1A1 (0.70) ALDH1A1KDM4ESMN1; SMN2CARM1PRMT6
Dibemethine SCHEMBL276863 0.74 ALDH1A1 (0.70) ALDH1A1KDM4ESMN1; SMN2CARM1PRMT6
SCHEMBL19082589 0.73 ALDH1A1 (0.56) ALDH1A1KDM4ESMN1; SMN2CARM1PRMT6
Dibemethine SCHEMBL2139708 0.72 ALDH1A1 (0.67) ALDH1A1KDM4ESMN1; SMN2CARM1PRMT6
SCHEMBL3152066 0.71 CARM1 (0.59) ALDH1A1KDM4ESMN1; SMN2CARM1PRMT6
SCHEMBL27858491 0.70 IDH1 (0.46) ALDH1A1KDM4ESMN1; SMN2TSHRCYP3A4
SCHEMBL10886152 0.69 CD44 (0.42) ALDH1A1KDM4ESMN1; SMN2TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997046539-A1 AMIDE DERIVATIVES OF SUBSTITUTED QUINOXALINE 2,3-DIONES AS GLUTAMATE RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-12-11 WO claimed
US-6268366-B1 Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists WARNER-LAMBERT COMPANY 2001-07-31 US disclosed
US-6191134-B1 STROKE THERAPY, ANTIISCHEMIC AGENTS, BRAIN DISORDERS WARNER-LAMBERT COMPANY 2001-02-20 US disclosed
US-6172065-B1 CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY 2001-01-09 US disclosed
US-6096744-A ANTICONVULSANTS WARNER-LAMBERT COMPANY (US) 2000-08-01 US disclosed
US-6063774-A NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 2000-05-16 US disclosed
WO-1998027097-A1 TRICYCLIC QUINOXALINE DERIVATIVES AS NEUROPROTECTIVE AGENTS WARNER-LAMBERT COMPANY (US) 1998-06-25 WO disclosed